Breast cancer statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Cases

New cases of breast cancer, 2015-2017, UK.

Deaths

Deaths from breast cancer, 2015-2017, UK.

Survival

Survive breast cancer for 10 or more years, 2013-2017, England

Preventable cases

Breast cancer cases are preventable, UK, 2015

 

  • There are around 55,200 new breast cancer cases in the UK every year, that's around 150 every day (2015-2017).
  • Breast cancer is the most common cancer in the UK, accounting for 15% of all new cancer cases (2017).
  • In females in the UK, breast cancer is the most common cancer, with around 54,700 new cases in 2017.
  • In males in the UK, breast cancer is not among the 20 most common cancers, with around 390 new cases in 2017.
  • Incidence rates for breast cancer in the UK are highest in people aged 90+ (2015-2017).
  • Each year around a quarter (24%) of all new breast cancer cases in the UK are diagnosed in people aged 75 and over (2015-2017).
  • Since the early 1990s, breast cancer incidence rates have increased by around a sixth (18%) in the UK. Rates in females have increased by almost a quarter (23%), and rates in males have remained stable (2015-2017).
  • Over the last decade, breast cancer incidence rates have increased by less than a twentieth (3%) in the UK. Rates in males have remained stable, and rates in females have increased by a twentieth (5%) (2015-2017).
  • More than 1 in 10 breast cancer cases are diagnosed late in England (2014), Scotland (2014-2015) and Northern Ireland (2010-2014).
  • Most invasive breast cancers occur in the upper-outer quadrant of the breast.
  • Incidence rates for breast cancer are projected to rise by 2% in the UK between 2014 and 2035, to 210 cases per 100,000 females by 2035.
  • Breast cancer incidence rates in England in females are 14% lower in the most deprived quintile compared with the least, and in males are similar in the most deprived quintile compared with the least (2013-2017).
  • Around 3,000 cases of breast cancer each year in England in females are linked with lower deprivation.
  • Breast cancer is more common in White females than in Asian or Black females.
  • An estimated 491,300 women who had previously been diagnosed with breast cancer were alive in the UK at the end of 2010.

See more in-depth breast cancer incidence (invasive) statistics

  • There are around 8,100 new breast carcinoma in situ cases in the UK every year, that's 22 every day (2015-2017).
  • In females in the UK, breast carcinoma in situ accounted for around 8,200 new cancer cases in 2017.
  • In males in the UK, breast carcinoma in situ accounted for around 40 new cancer cases in 2017.
  • Incidence rates for breast carcinoma in situ in the UK are highest in people aged 65 to 69 (2015-2017).
  • Each year around a tenth (9%) of all new breast carcinoma in situ cases in the UK are diagnosed in people aged 75 and over (2015-2017).
  • Since the early 1990s, breast carcinoma in situ incidence rates have almost tripled (194%) in the UK. Rates in females have almost tripled (195%), and rates in males have increased by more than nine-tenths (93%) (2015-2017).
  • Over the last decade, breast carcinoma in situ incidence rates have increased by a third (33%) in the UK. Rates in males have remained stable, and rates in females have increased by a third (33%) (2015-2017).
  • Most in situ breast carcinomas are intraductal.
  • In situ breast carcinoma is more common in White females than in Asian or Black females.
  • Breast carcinoma in situ incidence rates in England in females are 28% lower in the most deprived quintile compared with the least, and in males are similar in the most deprived quintile compared with the least (2013-2017).
  • Around 910 cases of breast carcinoma in situ each year in England in females are linked with lower deprivation.
  • An estimated 63,800 women who had previously been diagnosed with in situ breast carcinoma were alive in the UK at the end of 2010.

See more in-depth in situ breast carcinoma incidence statistics

  • There are around 11,400 breast cancer deaths in the UK every year, that's 31 every day (2015-2017).
  • Breast cancer is the 4th most common cause of cancer death in the UK, accounting for 7% of all cancer deaths (2017).
  • In females in the UK, breast cancer is the 2nd most common cause of cancer death, with around 11,400 deaths in 2017.
  • In males in the UK, breast cancer is not among the 20 most common causes of cancer death, with around 80 deaths in 2017.
  • Mortality rates for breast cancer in the UK are highest in people aged 90+ (2015-2017).
  • Since the early 1970s, breast cancer mortality rates have decreased by almost two-fifths (39%) in the UK. Rates in females have decreased by more than a third (35%), and rates in males have decreased by almost half (45%).
  • Over the last decade, breast cancer mortality rates have decreased by around a fifth (21%) in the UK. Rates in females have decreased by around a fifth (19%), and rates in males have decreased by more than a quarter (27%).
  • Mortality rates for breast cancer are projected to fall by 26% in the UK between 2014 and 2035, to 31 deaths per 100,000 females by 2035.
  • Breast cancer deaths in England are more common in females living in the most deprived areas. There is no association for males.

See more in-depth breast cancer mortality statistics

  • More than 9 in 10 (95.8%) of women diagnosed with breast cancer in England survive their disease for one year or more (2013-2017).
  • Almost 9 in 10 (85%) of women diagnosed with breast cancer in England survive their disease for five years or more (2013-2017).
  • It is predicted that around 3 in 4 (75.9%) of women diagnosed with breast cancer in England survive their disease for ten years or more (2013-2017).
  • Breast cancer survival in England is highest for women diagnosed aged 60-69, probably because of screening, and less favourable tumour characteristics in younger women (2009-2013).
  • Around 9 in 10 women in England diagnosed with breast cancer between ages 40-69 survive their disease for five years or more, compared with 7 in 10 women diagnosed aged 80 and over (2009-2013).
  • Breast cancer survival is improving and has doubled in the last 40 years in the UK.
  • In the 1970s, 4 in 10 women diagnosed with breast cancer survived their disease beyond ten years, now it's around 8 in 10.
  • When diagnosed at its earliest stage, all (100%) people with breast cancer will survive their disease for one year or more, compared with 2 in 3 (66%) people when the disease is diagnosed at the latest stage.
  • When diagnosed at its earliest stage, almost all (98%) people with breast cancer will survive their disease for five years or more, compared with around 1 in 4 (26%) people when the disease is diagnosed at the latest stage.
  • Five-year relative survival for breast cancer in women is below the European average in England, Wales and Scotland but similar to the European average in Northern Ireland.
  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 7 UK females will be diagnosed with breast cancer in their lifetime.
  • 23% of breast cancer cases in the UK are preventable.
  • Less than 1% of breast cancer cases in the UK are caused by oral contraceptives.
  • 2% of breast cancer cases in the UK are caused by post-menopausal hormones.
  • 8% of breast cancer cases in the UK are caused by overweight and obesity.
  • 8% of breast cancer cases in the UK are caused by alcohol drinking.
  • 5% of breast cancer cases in the UK are caused by not breastfeeding.

See more in-depth breast cancer risk statistics

  • 'Two-week wait' is the most common route to diagnosing breast cancer.
  • Screening is the route with the highest proportion of cases diagnosed at an early stage, for breast cancer.
  • 'Two-week wait' standards are met by all countries, '31-day wait' is met by all but Wales, and ‘62-day wait’ is met by all but Wales for breast cancer.
  • 81% of patients diagnosed with breast cancer have surgery to remove the tumour as part of their primary cancer treatment.
  • 63% of patients diagnosed with breast cancer have radiotherapy as part of their primary cancer treatment.
  • 34% of patients diagnosed with breast cancer have chemotherapy as part of their primary cancer treatment.
  • Around three-quarters (74%) of women in the UK who are invited for breast screening are screened with a definitive usable result within 6 months of invitation.
  • Breast screening uptake in the UK has fallen slightly since 2010/11.
  • Less than 1 per 100 screened women in the UK have cancer detected through breast screening. Around 8 in 10 of these are invasive cancers.
  • For every breast cancer death prevented through screening, 3 women will be overdiagnosed.

See more in-depth breast cancer diagnosis and treatment statistics

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.